SIGNIFICANT developments from Germany this week helped add to the momentum of interest in cannabis stocks initially driven by President Joe Biden’s recent announcements.
This...
FOLLOWING a two-and-half-year break oil products have returned to the Danish medical cannabis access programme in a move which is likely to provide a...
Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022
BC: What are the main opportunities...
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no...